On the upside
Shares of China Auto Logistics (NYSE: CALI) continued climbing after reporting sharply higher third quarter revenue yesterday.
AcelRx Pharmaceuticals (Nasdaq: ACRX) reported positive results from a Phase 3 trial of its investigational sublingual Sufentanil NanoTab PCA System. On the downside
Tranzyme (Nasdaq: TZYM) reported that its stomach paralysis treatment TZP-102 failed a midstage clinical trial.
Safe Bulkers (NYSE: SB) reported higher third quarter earnings and revenue but the drybulk transportations services provider cut its quarterly dividend.
Representative Mike Rogers said that OSI Systems (Nasdaq: OSIS) may have falsified test data for its passenger scanning machines.
In the broad market, declining issues outpaced advancers by a margin of nearly 7 to 2 on the NYSE and by nearly 2 to 1 on Nasdaq. The Russell 2000 which tracks small cap stocks fell 7 points to 765.